miR-210 as a marker of chronic hypoxia, but not a therapeutic target in prostate cancer

Laurent Quero*, Ludwig Dubois, Natasja G. Lieuwes, Christophe Hennequin, Philippe Lambin

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

45 Downloads (Pure)

Fingerprint

Dive into the research topics of 'miR-210 as a marker of chronic hypoxia, but not a therapeutic target in prostate cancer'. Together they form a unique fingerprint.

Keyphrases

INIS

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology